The above chart presents the market trend analysis for mpi pharmaceutical gmbh from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3 transactions, with a transaction quantity of 230 and a transaction weight of 3920.
5vamsi labs ltd.
indiabuyer,they trade on 2023-07-11
173.55%
>
+View All
Products
Total 51
ProductsTransactionsPerDetail
chloro benzene 1019.61%>
ev 815.69%>
masc 815.69%>
strawberry 815.69%>
gel 815.69%>
+View All
Hscode rank
Total 104
HSCode NameTransactionsPerDetail
HS 290391301019.61%>
HS 300670000000815.69%>
HS 2933399059.8%>
HS 2942009047.84%>
HS 2922509035.88%>
+View All
Trading Area
Total 15
AreaTransactionsPerDetail
india38480.17%>
turkey398.14%>
panama173.55%>
mexico153.13%>
peru51.04%>
+View All
Port statistics
Total 38
Port NameTransactionsPerDetail
hamburg16033.4%>
hamburg fuhlsbuett4910.23%>
bogota132.71%>
manzanillo132.71%>
puerto cort¿s81.67%>
+View All
mpi pharmaceutical gmbh is International Buyer&Supplier,
and primarily engages in the import and export business of products such as chloro benzene,ev,masc.
According to the 52wmb.com global trade database, as of 2026-02-28, the company has completed 11928 international trades,
with its main trading regions covering india,turkey,panama etc.
The core products include HS29039130,HS300670000000,HS29333990 etc,
often transported via hamburg,port hamburg fuhlsbuett, port bogota etc,
and its main trading partners are turkuaz medikal kozmetik ve diş tic.ltd.şti.,sun pharmaceutical industries ltd.,embio ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on mpi pharmaceutical gmbh is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.